You are in: eMedicine Specialties > Emergency Medicine > WARFARE - CHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR AND EXPLOSIVES CBRNE - RicinArticle Last Updated: Feb 14, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Ferdinando L Mirarchi, DO, Medical Director, Department of Emergency Medicine, Hamot Medical Center; Assistant Clinical Professor, Department of Emergency Medicine, Drexel University School of Medicine Ferdinando L Mirarchi is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Emergency Medicine Residents Association Editors: Jerry L Mothershead, MD, Medical Readiness Consultant, Medical Readiness and Response Group, Battelle Memorial Institute; Advisor, Technical Advisory Committee, Emergency Management Strategic Healthcare Group, Veteran's Health Administration; Adjunct Associate Professor, Department of Military and Emergency Medicine, Uniformed Services University of the Health Sciences; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Robert G Darling, MD, FACEP, Clinical Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Director, Center for Disaster and Humanitarian Assistance Medicine Author and Editor Disclosure Synonyms and related keywords: Ricinus communis, toxin, agent of biological warfare, weapon of mass destruction, WMD, beans of castor plant, castor beans, food contaminant, water contaminant, hematemesis, bloody diarrhea, melena, food poisoning, hypoxia, cyanosis, labored breathing, tachypnea, tachycardia, progressive respiratory failure, ricin, biological warfare agent, terrorism INTRODUCTIONBackgroundRicin is a potent toxin that has potential to be used as an agent of biological warfare and as a weapon of mass destruction (WMD). Ricin is widely available, easily produced, and derived from the beans of the castor plant (Ricinus communis). In attempting to evaluate and discuss agents that can be used as WMDs, the question, "What can cause a maximum credible event?" is hopefully answered. A maximum credible event is one that could cause a large loss of life in addition to disruption, panic, and an overwhelming use of civilian healthcare resources. For an agent to be considered capable of causing a maximum credible event, it should be highly lethal, inexpensively and easily produced in large quantities, stable in aerosol form, and have the ability to be dispersed (1-5 µm). The ideal agent also is communicable from person to person and has no treatment or vaccine. When ricin's characteristics are applied to this model, its use appears limited but should not be underestimated. Ricin is produced easily and inexpensively, is highly toxic, is stable in aerosolized form, and has no treatment or approved vaccine. Its toxicity when compared to living replicating biological agents limits ricin's use. A large amount of ricin is necessary to produce the desired effect of a WMD. For example, the amount of ricin necessary to cover a 100-km2 area and cause 50% lethality, assuming aerosol toxicity of 3 mcg/kg and optimum dispersal conditions, is approximately 4 metric tons, whereas only 1 kg of Bacillus anthracis is required. Ricin, however, would have efficacy as a disabling agent. Its use as a food and water contaminant easily could incapacitate many and overwhelm local healthcare resources. Thus, its use as a food and water contaminant is a major concern because of ricin's ease of availability. Ricin can be disseminated as an aerosol, by injection, or as a food and water contaminant. PathophysiologyRicin is a widely available potential toxin that is produced easily. It is a potent protein derived from the beans of the castor plant (R communis). Castor beans are used in the production of castor oil, a brake and hydraulic fluid constituent. The aqueous phase of the process, termed the "waste mash," is 5-10% ricin. Separating this 66,000-dalton protein requires chromatography, a common undergraduate chemistry skill. Ricin's ease of availability and its lethality make it an attractive agent for use in biological warfare and for potential use as a WMD. Routes of exposure are respiratory (inhaled aerosol), gastrointestinal (GI [ingested]), and parenteral (injected). Clinical manifestations depend on the route of exposure and the amount of absorption. Ricin is composed of 2 hemagglutinins and 2 toxins. The toxins RCL III and RCL IV are dimers of approximately 66,000 daltons in molecular weight. The toxins have an "A" and a "B" chain, which are polypeptides and joined by a disulfide bond. The B chain binds to cell surface glycoproteins and affects entry into the cell by an unknown mechanism. The A chain acts on the 60S ribosomal subunit and prevents the binding of elongation factor-2. This inhibits protein synthesis and leads to cell death. This basic structure of ricin is similar to those of the botulinum toxin, cholera toxin, diphtheria toxin, tetanus toxin, and insulin. FrequencyUnited StatesFrom 1991-1997, 3 cases were related to ricin. In 1991 in Minnesota, 4 members of the Patriots Council, an extremist group that held antigovernment and antitax ideals and advocated the overthrow of the US government, were arrested for plotting to kill a US marshal with ricin.1 The ricin was produced in a home laboratory. They planned to mix the ricin with the solvent dimethyl sulfoxide (DMSO) and then smear it on the door handles of the marshal's vehicle. The plan was discovered, and the 4 men were convicted. In 1995, a man entered Canada from Alaska on his way to North Carolina.1 Canadian custom officials stopped the man and found him in possession of several guns, $98,000, and a container of white powder, which was identified as ricin. Lastly, in 1997, a man shot his stepson in the face. Investigators discovered a makeshift laboratory in his basement and found agents such as ricin and nicotine sulfate. Three US Senate office buildings were closed February 3, 2004, after ricin was found in the mailroom that serves Senate Majority Leader Bill Frist's office. No injuries were reported. InternationalIn December 2002, 6 terrorist suspects were arrested in Manchester, England; their apartment was serving as a "ricin laboratory."1 Among them was a 27-year-old chemist who was producing the toxin. Later, on January 5, 2003, British police raided 2 residences around London and found traces of ricin, which led to an investigation of a possible Chechen separatist plan to attack the Russian embassy with the toxin; several arrests were made.2 Mortality/MorbidityMortality and morbidity depend on the route and amount of exposure.
CLINICALHistory
PhysicalPerform a complete physical examination with any exposure.
DIFFERENTIALSCBRNE - Anthrax Infection CBRNE - Lung-Damaging Agents, Phosgene CBRNE - Q Fever CBRNE - Staphylococcal Enterotoxin B Cellulitis Tick-Borne Diseases, Q Fever Tick-Borne Diseases, Tularemia
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Cefazolin (Ancef) |
|---|---|
| Description | First-generation semisynthetic cephalosporin that arrests bacterial cell wall synthesis, inhibiting bacterial growth. |
| Adult Dose | 1-2 g IV/IM q6-8h |
| Pediatric Dose | 25-50 mg/kg/d IV/IM divided q6-8h |
| Contraindications | Documented hypersensitivity; relative contraindication for patients who have a true anaphylactic reaction to penicillin-type agents; cross-reaction is reportedly 3-8% |
| Interactions | Probenecid prolongs effect of cefazolin; coadministration with aminoglycosides may increase renal toxicity; may yield false-positive urine-dip test for glucose |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Adjust dose in renal impairment; superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy |
Perform adequate volume resuscitation of patients with isotonic fluids and packed red blood cells prior to using or in conjunction with these agents; do not use in place of volume resuscitation. Choice of agent usually is determined by physician preference.
| Drug Name | Dopamine (Intropin) |
|---|---|
| Description | Probably most well-known and used pressor agent. Standard mixture of 200 mg in 250 cm3 produces a concentration of 800 mcg/cm3; administer IV. |
| Adult Dose | Low dose: 0.5-5 mcg/kg/min IV Medium dose: 5-10 mcg/kg/min IV High dose: >10 mcg/kg/min IV |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity; relative contraindications are tachycardia and myocardial ischemia; increases myocardial demand and oxygen consumption; reportedly causes sudden cardiac death in conjunction with Dilantin (diphenylhydantoin); incidence is rare and never was studied adequately; should not deter use |
| Interactions | Phenytoin, alpha- and beta-adrenergic blockers, general anesthesia, and MAOIs increase and prolong effects of dopamine |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Closely monitor urine flow, cardiac output, pulmonary wedge pressure, and blood pressure during infusion; prior to infusion, correct hypovolemia with either whole blood or plasma, as indicated; monitoring central venous pressure or left ventricular filling pressure may be helpful in detecting and treating hypovolemia |
| Drug Name | Norepinephrine (Levophed) |
|---|---|
| Description | Often a second-line agent but can be used as a first-line agent; can be used with dopamine. Standard mixture of 4 mg in 250 cm3 produces a concentration of 16 mcg/cm3; administer IV. |
| Adult Dose | 2-4 mcg/min IV; can be increased by 2-4 mcg/min q5-10min prn |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity; relative contraindications are tachycardia and myocardial ischemia; increases myocardial demand and oxygen consumption |
| Interactions | Effects increase when administered concurrently with TCAs, MAOIs, antihistamines, guanethidine, methyldopa, and ergot alkaloids; atropine may block reflex tachycardia caused by norepinephrine and enhances pressor response |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Correct blood-volume depletion, if possible, before giving norepinephrine therapy; extravasation may cause severe tissue necrosis and thus should be administered into a large vein; caution in occlusive vascular disease |
These agents are used to induce active immunity. Update tetanus status if unknown.
| Drug Name | Diphtheria and tetanus toxoid (Decavac) |
|---|---|
| Description | Used to induce active immunity against tetanus in selected patients. |
| Adult Dose | 0.5 mL IM |
| Pediatric Dose | <7 years: Not recommended >7 years: Administer as in adults |
| Contraindications | Documented hypersensitivity; a history of any type of neurologic symptoms or signs following administration of this product; FDA recommends that elective tetanus immunization be deferred during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis |
| Interactions | Patients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization due to poor immune response; cimetidine may enhance or augment delayed-hypersensitivity responses to skin-test antigens; avoid concurrent use of medication with systemic chloramphenicol since may impair amnestic response to tetanus toxoid; concurrent use of tetanus immune globulin may delay development of active immunity by several days (interaction is nevertheless clinically insignificant and does not preclude concurrent use) |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Do not use to treat actual tetanus infections or for immediate prophylaxis of unimmunized individuals (use instead tetanus antitoxin, preferably human tetanus immune globulin); diminished antibody response to active immunization may be seen in patients receiving immunosuppressive therapy; better to defer primary diphtheria immunization until immunosuppressive therapy discontinued; routine immunization of symptomatic and asymptomatic HIV-infected persons is recommended |
Reversible competitive blockers of histamine at H2 receptors, particularly those in the gastric parietal cells where they inhibit acid secretion. The H2 antagonists are highly selective, do not affect H1 receptors, and are not anticholinergic agents.
| Drug Name | Famotidine (Pepcid) |
|---|---|
| Description | Competitively inhibits histamine at H2 receptor of gastric parietal cells, resulting in reduced gastric acid secretion, gastric volume, and reduced hydrogen concentrations. |
| Adult Dose | Normal renal function: 20 mg IV q12h Renal failure: 20 mg IV qd |
| Pediatric Dose | Normal renal function: 0.5 mg/kg IV q12h Renal failure: No standard recommendations; consider decreasing dose to 0.5 mg/kg IV qd |
| Contraindications | Documented hypersensitivity |
| Interactions | May decrease effects of ketoconazole and itraconazole |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | If changes in renal function occur during therapy, consider adjusting dose or discontinuing treatment |
Used to inhibit or reduce absorption of the toxin.
| Drug Name | Activated charcoal (Liqui-Char, Actidose Aqua) |
|---|---|
| Description | Emergency treatment in poisoning caused by drugs and chemicals. Network of pores present in activated charcoal adsorbs 100-1000 mg of drug per gram of charcoal. Does not dissolve in water. For maximum effect, administer within 30 min after ingesting poison. |
| Adult Dose | 25-100 g PO, 1 g/kg PO, or 10 times weight of ingested poison; give as susp in 4-8 oz of water |
| Pediatric Dose | <1 year: Not recommended >1 year: Administer as in adults |
| Contraindications | Documented hypersensitivity; poisoning or overdosage of mineral acids and alkalies |
| Interactions | May inactivate ipecac syrup if used concomitantly; effectiveness of other medications decreases with coadministration; do not mix charcoal with sherbet, milk, or ice cream (decreases adsorptive properties of activated charcoal) |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Not very effective in poisonings of ethanol, methanol, and iron salts; induce emesis before giving activated charcoal; after emesis with ipecac syrup, patient may not tolerate activated charcoal for 1-2 h; can administer in early stages of gastric lavage; without sorbitol gastric lavage, returns are black |
The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Michael P Allswede, DO, to the development and writing of this article.
| Media file 1: Chemical Terrorism Agents and Syndromes. Signs and symptoms. Chart courtesy of North Carolina Statewide Program for Infection Control and Epidemiology (SPICE), copyright University of North Carolina at Chapel Hill, www.unc.edu/depts/spice/chemical.html. | |
![]() | View Full Size Image | Media type: Image |
Article Last Updated: Feb 14, 2008